Recurrent Or Refractory Neuroblastoma clinical trials

Explore recruiting recurrent or refractory neuroblastoma clinical trials.

Recruiting recurrent or refractory neuroblastoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Or Refractory Neuroblastoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTA0-Tyr3-Octreotate in Children with Refractory or Recurrent Neuroblastoma expressing somatostatin receptors

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

A5481092: PHASE 1/2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE OR IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS

Sweden, France, Czechia, Slovakia, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Recurrent Or Refractory Neuroblastoma trials by city

Recurrent Or Refractory Neuroblastoma in Toronto Recurrent Or Refractory Neuroblastoma in Vancouver Recurrent Or Refractory Neuroblastoma in Montreal Recurrent Or Refractory Neuroblastoma in Calgary Recurrent Or Refractory Neuroblastoma in Edmonton Recurrent Or Refractory Neuroblastoma in Ottawa Recurrent Or Refractory Neuroblastoma in Winnipeg Recurrent Or Refractory Neuroblastoma in Quebec City Recurrent Or Refractory Neuroblastoma in Hamilton Recurrent Or Refractory Neuroblastoma in Kitchener Recurrent Or Refractory Neuroblastoma in London Recurrent Or Refractory Neuroblastoma in Halifax Recurrent Or Refractory Neuroblastoma in New York Recurrent Or Refractory Neuroblastoma in Los Angeles Recurrent Or Refractory Neuroblastoma in Chicago Recurrent Or Refractory Neuroblastoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease